The effects of TKIs are not limited to VEGF signaling but also block the cancer-intrinsic pathways that promote immune cell exclusion, such as Wnt-β-catenin, MYC, or PI3K-PTEN signaling pathways [123]. The gene discussed is VEGFA; the disease is cancer.